QA: Sarepta Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000873303_2023_Sarepta_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000873303, Sarepta Therapeutics Inc.

  xvar xval
0 AssetsCurrent 2,557,861,000
1 IntangibleAssetsNetIncludingGoodwill 7,578,000
2 PropertyPlantAndEquipmentNet 180,037,000
3 remainder_Assets 382,890,000
4 LiabilitiesCurrent 619,604,000
5 LiabilitiesNoncurrent 542,620,000
6 remainder_Liabilities 1,581,192,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 451,421,000
9 ResearchAndDevelopmentExpense 877,090,000
10 remainder_Expenses 154,228,000
11 remainder_Revenues 933,013,000
12 remainder_NetIncome -153,762,000
13 remainder_ComprehensiveNetIncome -1,644,000
  yvar yval
0 Assets 3,128,366,000
1 Liabilities 2,743,416,000
2 Expenses 1,482,739,000
3 Revenues 933,013,000
4 StockholdersEquity 384,950,000
5 NetIncome -703,488,000
6 ComprehensiveNetIncome -704,310,000
7 BaseVar 4,221,470,000
8 EconomicCapitalRatio -0.0144

Edgar->Model Mapping

Feature Distribution

Change over Time